| Title |
Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19
|
|---|---|
| Published in |
Nature Reviews Clinical Oncology, November 2020
|
| DOI | 10.1038/s41571-020-00448-y |
| Pubmed ID | |
| Authors |
Rahul Banerjee, Vinay Prasad |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 29% |
| United Kingdom | 4 | 11% |
| Canada | 2 | 5% |
| France | 2 | 5% |
| Australia | 2 | 5% |
| Switzerland | 1 | 3% |
| Italy | 1 | 3% |
| India | 1 | 3% |
| Japan | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 13 | 34% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 20 | 53% |
| Scientists | 10 | 26% |
| Practitioners (doctors, other healthcare professionals) | 5 | 13% |
| Science communicators (journalists, bloggers, editors) | 3 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 69 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 9 | 13% |
| Student > Bachelor | 7 | 10% |
| Student > Postgraduate | 5 | 7% |
| Researcher | 5 | 7% |
| Lecturer | 4 | 6% |
| Other | 12 | 17% |
| Unknown | 27 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 26% |
| Nursing and Health Professions | 6 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Environmental Science | 3 | 4% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 7 | 10% |
| Unknown | 30 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2023.
All research outputs
#1,385,239
of 25,284,710 outputs
Outputs from Nature Reviews Clinical Oncology
#345
of 2,191 outputs
Outputs of similar age
#35,697
of 429,484 outputs
Outputs of similar age from Nature Reviews Clinical Oncology
#7
of 25 outputs
Altmetric has tracked 25,284,710 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,191 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,484 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.